Related Experiment Video

Updated: Jun 4, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Aging and arterial-cardiac interactions in the elderly

Yoshiaki Maruyama1

  • 1Department of Health Promotion, Saitama Medical Center, Saitama Medical, University, Kawagoe, Japan. ymaru@saitama-med.ac.jp

International Journal of Cardiology
|February 15, 2011
PubMed

Insights

Cardiovascular aging involves distinct changes in arteries and the heart, influenced by risk factors like hypertension and diabetes. Understanding cellular aging is key to differentiating normal aging from disease-related remodeling.

Area of Science:

  • Cardiovascular Aging Research
  • Gerontology
  • Cardiovascular Physiology

Background:

  • Cardiovascular system undergoes age-related morphological and functional changes.
  • These changes are distinct from arteriosclerosis and influenced by risk factors like hypertension and diabetes.
  • Cellular aging mechanisms, including cell death, dysfunction, and matrix fibrosis, are central to cardiovascular aging.

Purpose of the Study:

  • To review the latest findings on aging-associated functional and morphological changes in arteries and the heart.
  • To elucidate the relationship between aging and cardiovascular system remodeling.
  • To describe the interactions between aging arteries and the heart.

Main Methods:

  • Review of recent studies on cardiovascular aging mechanisms.
  • Analysis of cellular aging phenomena.
  • Examination of arterial-cardiac interactions.

Main Results:

  • Cardiovascular aging involves specific changes distinct from arteriosclerosis.
  • Aging-related changes in the heart and arteries exhibit different timelines (early, delayed, linear types).
  • Arteries and the heart undergo reciprocal changes throughout the aging process.

Conclusions:

  • Clarifying cellular aging is crucial for understanding cardiovascular aging and remodeling.
  • Cardiovascular aging is a complex process with distinct temporal patterns in the heart and arteries.
  • Interactions between aging arteries and the heart play a significant role in cardiovascular health over time.

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...